Nov 292016
 

Hundreds of ultrafast, high-powered charging stations planned for electric cars in Europe

BMW AG, Daimler AG and Volkswagen AG said Tuesday they plan to build together with Ford Motor Co. a network of hundreds of ultrafast, high-powered charging stations for electric cars in Europe.

That’s a good start on standardization and providing customer comfort in buying vehicles that require a way to refuel (electric charging) that is different and currently less available and more unknown.

Nov 272016
 

Below are links to three C-SPAN Q & A podcasts that are helpful in understanding the past presidential election. They are listed in the order I listened to them. You could probably listen in whatever order you wish. 

 

J.D. Vance

Author J.D. Vance discusses his memoir, [Hillbilly Elegy], about growing up in a poor, white family that has its roots in Appalachia.

 

David Cay Johnston

Author and columnist David Cay Johnston talks about this book, [The Making of Donald Trump], in which he takes a critical look at the 2016 Republican presidential nominee.

 

Nancy Isenberg

Historian Nancy Isenberg talks about her book, [White Trash], which examines the history of the class system in the United States.

Nov 272016
 

Drug price increases will likely bring more regulation in the future. In the short run that is probably not the case. The balance of power in Washington can change very quickly. 

 

Drugmakers Find Competition Doesn’t Keep a Lid on Prices

*Link may be behind the Wall Street Journal paywall. Try pasting the title in a Google Search

http://www.wsj.com/articles/drugmakers-find-competition-doesnt-keep-a-lid-on-prices-1480248003

 

“The two companies, though rivals, followed a common industry practice: raising prices almost in lockstep.”

 

““You’re not rewarded for having a low price and for the most part, the market doesn’t punish a high price,” says Mick Kolassa”

 

“The freedom to raise, rather than slash, prices in the face of competition is a big reason why U.S. prescription-drug spending has surged by close to 10% on average annually in recent years to $310 billion in 2015”

 

“Tandem drug-price increases for other ailments have prompted lawmakers to call for investigations into potential collusion.”

 

“Tandem increases can be perfectly legal, so long as companies don’t confer with each other, says Herbert Hovenkamp”

 

“In compliance training, companies tell employees not to discuss pricing with rivals. But when it comes to drugs, list prices are public.”

 

““Any profit-optimizing company is going to want to get as much price as they can get,””